CILOSTAZOL DID NOT INDUCE ANY ADVERSE REACTIONS IN CORONARY ARTERIAL DISEASE (NON-ST ELEVATION MYOCARDIAL INFARCTION) WITH CONGESTIVE HEART FAILURE COMORBIDITY: A CASE REPORT
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i1.14721Abstract
The study to monitor the adverse reactions related to cilostazol used in coronary arterial disease with congestive heart failure comorbidity. This
case report describes monitored 63-year-old males with dyspnea that had recently begun using cilostazol after switched from aspirin caused by
asthma related to aspirin. After 10 days monitored for adverse reactions of cilostazol used, revealed there was no adverse reaction to be related to
cilostazol and the patient came home with improvement. Cilostazol did not show any adverse reactions in this report. However, more data and longterm
monitoring willneeded.In addition, biologic variations may influence. Therefore,
need to determine which population do not affect the harm of cilostazol.
Keywords: Dyspnea, Cilostazol, Monitoring.
Downloads
References
Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy, A Patophysiologic Approach. New York: Mc Graw Hill; 2008.
Han Y, Li Y, Wang S, Jing Q, Wang Z, Wang D, et al. Cilostazol in addition to aspirin and clopidogrel imporves long-term outcomes after percuteneous coronary intervention with acute coronary syndrome: A randomized controled study. Am Heart J
;157(4):733-9.
Approval of New Drug Application for Pletal (Cilostazol). Letter to Otsuka American Pharmaceutical, Inc., from Center for Drug Evaluation and Research, Food and Drug Administration, Department of Health & Human Services; Rockville, MD, January 15, 1999. Availablefrom:http://www.fda.gov/cder/news/cilostazol/20863appletter.htm.
Katzung BG, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. New York: McGraw Hill; 2012.
Gamssari F, Mahmood H, Ho JS, Villareal RP, Liu B, Rasekh A, et al. Rapid ventricular tachycardias associated with cilostazol use. Tex Heart Inst J 2002;29(2z):140-2.
Setyopranoto I, Wibowo S, Tjandrawinata RR. Hemostasis profile and clinical outcome of acute ischemic stroke patients treated with oral lumbrokinase DLBS1033: A comparative study versus aspirin and clopidogrel. Asian J Pharm Clin Res 2016;9(1):186-92.
Sweetman SC, editor. Martindale the Complete Drugs Reference. London: Pharmaceutical Press; 2009.
Kelley RA, Smith TW. Pharmacological treatment of heart failure. In: Hardman JG, Limbird LE, editors. Goodman & Gilman’s the Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw- Hill; 1996. p. 809-38.
Cilostazol†July 6, 2016. Available from: https://www.drugs. com>cdi>cilostazol.html. [Last retrieved on 2016 Jul 20].
Cone J, Wang S, Tandon N, Fong M, Sun B, Sakurai K, et al. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells. J Cardiovasc Pharmacol 1999;34(4):497-504.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
